HLTH 2025

We’re living in an era where liquid biopsies can detect cancer years before symptoms appear, AI can analyze tumor genetics in real-time to personalize treatment protocols, and immunotherapies are turning terminal diagnoses into chronic conditions, yet we’re still losing 600,000 Americans to cancer every year. With all this innovation brewing, we have to ask, is this the best we can do?

Read full session description.

Osteoporosis is a silent epidemic—affecting more than 200 million people worldwide—yet it often goes undiagnosed and undertreated. In this session, Andrea Fox, DMSc, MHA, PA-C, spotlights Viz Osteoporosis, an AI-enabled clinical decision support tool currently under investigation in a real-world research study sponsored by Amgen.The discussion will highlight strategies for establishing a clear, streamlined pathway from risk identification to the delivery of individualized fracture risk reduction care plans—enabling clinicians to close critical care gaps and advance health equity, particularly for underserved populations.